Triple

T5932313
Position Surface form Disambiguated ID Type / Status
Subject ICH Management Committee E131965 entity
Predicate parentOrganization P254 FINISHED
Object International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E23680 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use | Statement: [ICH Management Committee, parentOrganization, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
Context triple: [ICH Management Committee, parentOrganization, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use]
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use chosen
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Federation of Pharmaceutical Industries and Associations
    The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085b75e88190a632f9691f9da48b completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c0389df18c81909027a9db7596f0c1 completed March 22, 2026, 6:44 p.m.
NED1 Entity disambiguation (via context triple) batch_69c11cc1ba0c8190be1c0defb35c5b0c completed March 23, 2026, 10:58 a.m.
Created at: March 22, 2026, 4 p.m.